In the BioHarmony Drug Report Database
Anhydron, Fluidil (cyclothiazide) is a small molecule pharmaceutical. Cyclothiazide was first approved as Anhydron on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. The pharmaceutical is active against solute carrier family 12 member 3. In addition, it is known to target glutamate receptor 1, glutamate receptor 2, glutamate receptor 3, and glutamate receptor 4.
Image (chem structure or protein)